Cases & Deals

BioTheryX establishes patent portfolio for anti-hematological malignancy therapies

Clients BioTheryX, Inc.

Jones Day assists BioTheryX, Inc. in the development of a global patent portfolio related to small molecule drugs for the treatment of hematological malignancies.